Structural characterization of the interaction of the polyene antibiotic Amphotericin B with DODAB bicelles and

Tiago R Oliveira1, Carlos R Benatti, M Teresa Lamy

  • 1Universidade de Sao Paulo, Sao Paulo, Brazil.

Insights

This study characterizes Amphotericin B (AmB) in DODAB bicelles, finding monomeric AmB binds to bicelle edges. This binding mechanism may reduce AmB toxicity and enhance antifungal efficacy.

Area of Science:

  • Biochemistry
  • Materials Science
  • Pharmacology

Background:

  • Amphotericin B (AmB) is a vital antifungal drug but causes significant nephrotoxicity.
  • Drug aggregation state is linked to Amphotericin B's toxicity and efficacy.
  • Formulating Amphotericin B with amphiphiles aims to improve its therapeutic index.

Purpose of the Study:

  • To structurally characterize Amphotericin B (AmB) when formulated with sonicated dioctadecyl dimethylammonium bromide (DODAB) aggregates.
  • To investigate the binding site and effects of monomeric AmB within DODAB bicelles.
  • To propose a novel method for quantifying amphiphile-bound monomeric AmB.

Main Methods:

  • Characterization of sonicated DODAB dispersions using biophysical techniques.
  • Solubility studies of monomeric AmB in DODAB bicelles versus vesicles.
  • Development and application of a new optical parameter for AmB-amphiphile binding.
  • Theoretical simulations of spin-labeled DODAB bicelles to probe AmB binding interactions.

Main Results:

  • Sonicated DODAB dispersions were confirmed to form bicelles.
  • Monomeric Amphotericin B exhibited higher solubility in DODAB bicelles compared to DODAB vesicles.
  • A new optical parameter was developed to estimate amphiphile-bound monomeric AmB.
  • Simulations revealed monomeric AmB preferentially binds to DODAB bicelle edges, rigidifying the structure and reducing local polarity.

Conclusions:

  • Monomeric Amphotericin B preferentially binds to the disordered lipid edges of DODAB bicelles.
  • This specific binding interaction offers a potential strategy for developing less toxic and more effective Amphotericin B formulations.
  • The findings support the use of bicelle-forming lipids, including natural lipid mixtures, as carriers for Amphotericin B.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Pinching-off of Coated Vesicles01:32

Pinching-off of Coated Vesicles

Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
COP Coated Vesicles00:59

COP Coated Vesicles

Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of different...